Active liver X receptor signaling in phagocytes in multiple sclerosis lesions

Jo Mailleux1, Tim Vanmierlo1, Jeroen Fj Bogie1

  • 1Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|March 10, 2017
PubMed
Abstract

Insights

Liver X receptors (LXRs) are activated in multiple sclerosis (MS) lesions. Myelin processing in macrophages increases LXR ligands like 27-hydroxycholesterol, suggesting a role in demyelination.

Area of Science:

  • Neuroimmunology
  • Cellular Biology
  • Molecular Medicine

Background:

  • Multiple sclerosis (MS) is a demyelinating disease of the central nervous system.
  • Phagocytes play a critical role in myelin debris clearance during demyelination.
  • Liver X receptors (LXRs) are nuclear receptors involved in cholesterol homeostasis and inflammation.

Purpose of the Study:

  • To identify liver X receptor (LXR) ligands in human macrophages after myelin phagocytosis.
  • To investigate LXR activation in active multiple sclerosis (MS) lesions.
  • To determine the role of myelin-derived lipids in LXR activation during demyelination.

Main Methods:

  • Real-time quantitative PCR and immunohistochemistry to assess LXR and response gene expression.
  • Gas chromatography/mass spectrometry to identify oxysterols and cholesterol precursors.
  • Myelin incubation assays with human monocyte-derived macrophages.

Main Results:

  • Myelin induced LXR response genes (ABCA1, ABCG1) in macrophages.
  • ABCA1 and apolipoprotein E (APOE) were upregulated in foamy phagocytes in active MS lesions.
  • 27-hydroxycholesterol (27OHC), an LXR ligand, increased in macrophages after myelin uptake.

Conclusions:

  • LXR response genes are upregulated in phagocytes within active MS lesions.
  • LXRs are activated in actively demyelinating phagocytes in MS.
  • Myelin contains LXR ligands, and 27OHC is generated during myelin processing, suggesting LXR activation by myelin-derived lipids in MS lesions.